Radiological protection in biomedical research

ICRP (1975). Report of the Task Group on Reference Man. ICRP Publication 23. Pergamon Press, Oxford.

ICRP (1983). Radionuclide Transformations, Energy and Intensity of Emissions. ICRP Publication 38. Annals of the ICRP 11–13. Pergamon Press, Oxford.

ICRP (1987). Radiation Dose to Patients from Radiopharmaceuticals. ICRP Publication 53. Annals of the ICRP 18(1–4). Pergamon Press, Oxford.

ICRP (1991). 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Annals of the ICRP 21(1–3). Pergamon Press, Oxford.

ICRP (1992). Age-Dependent Doses to Members of the Public from Intake of Radionuclides. ICRP Publication 56, Part 2. (To appear in the Annals of the ICRP) Pergamon Press, Oxford.

Hirsch J. Farquhar J. W. Ahrens J. E. H. Petersen M. L. Stoffel W. (1960). Studies of adipose tissue in man. J. Clin. Nutr. 8, 499–510.

Malmendier C. L. Delcroix C. Berman M. (1974). Interrelations in oxidative metabolism of free fatty acids, glucose and glycerol in normal and hyperlipemic patients. A compartmental model. J. Clin. Invest. 54, 461–476.

Pedersen N. T. Marqversen J. (1981). Metabolism of ingested ¹⁴C-triolein. Estimation of radiation dose in tests of lipid assimilation using ¹⁴C- and ³H-labelled fatty acids. Eur. J. Nucl. Med. 6, 327–329.

ICRP (1975). Report of the Task Group on Reference Man, ICRP Publication 23. Pergamon Press, Oxford.

Hirsch J. Farquhar J. W. Ahrens J. E. H. Petersen M. L. Stoffel W. (1960). Studies of adipose tissue in man. J. Clin. Nutr. 8, 499–510.

Malmendier C. L. Delcroix C. Berman M. (1974). Interrelations in oxidative metabolism of free fatty acids, glucose and glycerol in normal and hyperlipemic patients. A compartmental model. J. Clin. Invest. 54, 461–476.

Pedersen N. T. Marqversen J. (1981). Metabolism of ingested ¹⁴C-triolein. Estimation of radiation dose in tests of lipid assimilation using ¹⁴C- and ³H-labelled fatty acids. Eur. J. Nucl. Med. 6, 327–329.

Costa D. C. Ell P. J. Cullum I. D. Jarritt P. H. (1986). The in vivo distribution of ^99mTc-HM-PAO in normal man. Nucl. Med. Comm. 7, 647–658.

ICRP (1987). Radiation Dose to Patients from Radiopharmaceuticals, ICRP Publication 53. Annals of the ICRP 18(1–4). Pergamon Press, Oxford.

Sharp P. F. Smith F. W. Gemmel H. G. Lyall D. Evans N. T. S. Gvozdanovic D. Davidson J. Tyrrell D. A. Pickett R. D. Nierinckx R. D. (1986). Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral flood flow: Human volunteer studies. J. Nucl. Med. 27, 171–177.

Soundy R. G. Tyrrell D. A. Pickett R. D. Stabin M. (1990). The radiation dosimetry of ^99mTc-exametazime. Nucl. Med. Comm. 11, 791–799.

Vestergren E. Jacobsson L. Mattsson S. Johansson L. Bjure J. Sixt R. Uvebrant P. (1991). Biokinetics and dosimetry of ^99mTc HM-PAO in children. In: Fifth International Radiopharmaceutical Dosimetry Symposium, Proceedings of a Conference held at Oak Ridge, Tennessee, U.S.A., May 7–10, 1991. (Eds Schlafke-Stelson A. Watson E.E. ) CONF-910529, Oak Ridge Associated Universities, Oak Ridge, Tennessee, U.S.A., pp 444–456.

Villanueva-Meyer J. Thompson D. Mena I. Marcus C. S. (1990). Lachrymal gland dosimetry for the brain imaging agent technetium-99m-HMPAO. J. Nucl. Med. 31, 1237–1239.

Bubeck B. Brandau W. Weber E. Kälble T. Parekh N. Georgi P. (1990). Pharmacokinetics of technetium-99m-MAG3 in humans. J. Nucl. Med. 31, 1285–1293.

Jafri R. A. Britton K. E. Nimmon C. C. Solanki K. Al-Nahhas A. Bomanji J. Fettich J. Hawkins L. A. (1988). Technetium-99m-MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders. J. Nucl. Med. 29, 147–158.

Stabin M. G. Taylor A. Jr Eshima D. Wooter W. (1992). Radiation dosimetry for Tc-99m-MAG3, technetium-99m-DTPA and iodine-131 OIH based on human distribution studies. J. Nucl. Med. 33, 33–40.

Taylor A. Jr Eshima D. Fritzberg A. R. Christian P. E. Kasina S. (1986). Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers. J. Nucl. Med. 27, 795–803.

Andersson L. Joensson B-A. Leide S. Mattsson S. Strand S-E. (1990). Biodistribution and retention of Tc-99m-HEXA-MIBI evaluated in the rat. Eur. J. Nucl. Med. (Supplement) 16, S105 (Abstract).

CRP (1979). Limits for Intakes of Radionuclides by Workers, ICRP Publication 30. Pergamon Press, Oxford.

ICRP (1987). Radiation Dose to Patients from Radiopharmaceuticals, ICRP Publication 53. Annals of the ICRP, 18(1–4). Pergamon Press, Oxford.

Leide S. Diemer H. Ahlgren L. Mattsson S. (1992). In vivo distribution and dosimetry of ^99mTc MIBI in man. In: Fifth International Radiopharmaceutical Dosimetry Symposium (Eds Schlafke-Stelson A. Watson E.E. ) CONF-910529, Oak Ridge Associated Universities, Oak Ridge, Tennessee, U.S.A., pp 483–497.

Wackers F. J. T. Berman D. S. Maddahi J. Watson D. D. Beller G. A. Strauss H. W. Bouscher C. A. Pickard M. Holman B. L. Fridrich L. Inglese E. Delaloye B. Bischof-Delaloye A. Camin L. McKusik K. (1989). Technetium-99m hexakis-2 methoxy isobutyl isonitrile; human biodistribution, dosimetry, safety, preliminary comparison to Tl-201 for myocardial perfusion imaging. J. Nucl. Med. 30, 301–311.